Directory
>
Julie Grant
Julie Grant
General Partner | Synthekine
San Francisco, California, United States
Julie Grant
Summary
Julie Grant is a seasoned venture capitalist based in San Francisco, California, with a robust background in biopharmaceuticals and biotechnology. She has held senior leadership roles, including General Partner at Canaan and Co-Founder and CEO of Day One Biopharmaceuticals, showcasing her entrepreneurial spirit and strategic vision. Julie's expertise spans across business development, drug development, and market analysis, making her a valuable asset in the life sciences sector. Her board memberships at various biotech firms reflect her commitment to advancing healthcare innovation. With a rich educational background from prestigious institutions like Stanford and Yale, she combines academic excellence with practical experience. Julie is passionate about nurturing startups and driving impactful investments in the biopharma space. Her diverse experience also includes significant roles in corporate strategy and project management at leading organizations.
Julie Grant
Work Experience
General Partner at
Canaan
December 2019 - Present
Board Member at
Synthekine
March 2019 - Present
Board Member at
Nocion Therapeutics, Inc.
February 2018 - Present
Chair Of The Board Of Directors at
Day One Biopharmaceuticals
September 2020 - June 2023
Co-Founder and Chief Executive Officer at
Day One Biopharmaceuticals
November 2018 - September 2020
Partner at
Canaan
September 2016 - December 2019
Board Observer at
Glooko
March 2015 - January 2019
Board Member at
Biden Cancer Initiative
June 2017 - November 2018
Board Observer at
Chrono Therapeutics
June 2014 - June 2018
Board Member at
Protagonist Therapeutics
July 2015 - December 2017
Principal at
Canaan
October 2014 - September 2016
Board Observer at
CytomX Therapeutics
July 2013 - October 2015
Seed Investor and Board Observer at
Cellular Research
December 2013 - August 2015
Board Observer at
ALDEA Pharma
July 2013 - June 2015
Associate at
Canaan
July 2013 - October 2014
Board Observer at
Dermira, Inc.
July 2013 - October 2014
Board Observer at
LABRYS BIOLOGICS, INC.
July 2013 - June 2014
Market Planning Manager - BioOncology New Products Lead at
Genentech
February 2010 - June 2011
Market Planning Manager - Tarceva at
Genentech
September 2008 - February 2010
BioOncology Project Manager at
Genentech
August 2006 - September 2008
Business Development Intern at
Genentech
March 2006 - April 2006
Licensing Intern at
Yale University Office Of Cooperative Research
August 2005 - September 2005
Summer Analyst, Americas Special Situations Group at
Goldman Sachs
June 2004 - August 2004
Julie Grant
Education
Stanford Graduate School of Business, Mba
January 2011 - January 2013
Amridge University, Mphil
January 2005 - January 2006
Yale University, B.S.
January 2001 - January 2005
Frequently Asked Questions about Julie Grant
What is Julie Grant email address?
Julie Grant's primary email address is ***********@dayonebio.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Julie Grant work for?
Julie Grant is a General Partner at Synthekine, a company specializing in Commercial physical research.
Where Julie Grant graduated from?
Julie Grant holds a degree in from Stanford Graduate School of Business.
How can I directly contact Julie Grant?
To contact Julie Grant directly, you can use the email address ***********@dayonebio.com. Complete contact information is available upon registration with Muraena.
Who is Julie Grant?
Julie Grant is a seasoned venture capitalist based in San Francisco, California, with a robust background in biopharmaceuticals and biotechnology. She has held senior leadership roles, including General Partner at Canaan and Co-Founder and CEO of Day One Biopharmaceuticals, showcasing her entrepreneurial spirit and strategic vision. Julie's expertise spans across business development, drug development, and market analysis, making her a valuable asset in the life sciences sector. Her board memberships at various biotech firms reflect her commitment to advancing healthcare innovation. With a rich educational background from prestigious institutions like Stanford and Yale, she combines academic excellence with practical experience. Julie is passionate about nurturing startups and driving impactful investments in the biopharma space. Her diverse experience also includes significant roles in corporate strategy and project management at leading organizations.
Julie`s contact details
***********@dayonebio.com
******@synthekine.com
Colleagues
VP Research, Head of Protein Sciences
Vice President, Clinical Development Operations at Synthekine
Vice President, Translational & Bioanalytical Sciences
Chief Business Officer
Chief Technology Officer
Chief Technical Officer
Vice President Regulatory Affairs
Vice President Intellectual Property
SVP, Finance and Operations
VP, Head of Business Development